Skip to main content

Table 4 Estimated Percentage of Diabetic BMS Patients Likely to Receive DES by Year Following DES Approval

From: Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents

 

Mean

Median

Min

Max

# of Panel Members Responding

% of Diabetic Bare Metal Stent Patients Receiving DES, 1st Year Following Approval

all patients

43.2%

40.0%

10.2%

90.0%

11

all patients with single-vessel

39.5%

30.0%

10.2%

80.0%

9

all patients with multi-vessel

61.4%

50.0%

30.0%

100.0%

7

% of Diabetic Bare Metal Stent Patients Receiving DES, 2nd Year Following Approval

all patients

60.6%

60.0%

25.5%

100.0%

11

all patients with single-vessel

57.9%

50.0%

25.5%

100.0%

9

all patients with multi-vessel

75.0%

75.0%

40.0%

100.0%

7

% of Diabetic Bare Metal Stent Patients Receiving DES, 3rd Year Following Approval

all patients

77.9%

80.0%

50.0%

100.0%

11

all patients with single-vessel

75.7%

80.0%

50.0%

100.0%

9

all patients with multi-vessel

81.4%

80.0%

50.0%

100.0%

7

% of Diabetic Bare Metal Stent Patients Receiving DES, 4th Year Following Approval

all patients

86.1%

90.0%

60.0%

100.0%

11

all patients with single-vessel

85.2%

90.0%

60.0%

100.0%

9

all patients with multi-vessel

87.1%

90.0%

60.0%

100.0%

8

% of Diabetic Bare Metal Stent Patients Receiving DES, 5th Year Following Approval

all patients

90.9%

90.0%

70.0%

100.0%

11

all patients with single-vessel

88.0%

90.0%

70.0%

100.0%

10

all patients with multi-vessel

89.0%

90.0%

70.0%

100.0%

10